American Society of Clinical Oncology

See schedule o:research initiatives - tapur/centra:asco's center for research and analytics "(centra)" leads asco's efforts in research and related to clinical cancer research. major programs and projects include: (1) the targeted agent and profiling utilization registry (tapur) study, which is a precision medicine basket trial that investigates the efficacy of more than 15 different anti-cancer targeted agents in patients with advanced cancers and has enrolled nearly 3,000 patients since it opened in 2016. tapur continues to publish trial results in peer-reviewed clinical cancer research journals and present results at clinical cancer research conferences; (2) asco's member research survey pool, which facilitates research of cancer care providers by disseminating surveys from meritorious survey research projects to asco members who have agreed to be a part of the survey pool; (3) the state of cancer care in america program, which assesses and reports on the state of and changes in cancer care in the us; (4) asco's work in improving access to clinical trials through training for sites; and (5) a patient-centered clinical trial, the cdk4/6 inhibitor dosing study, which opened to enrollment in december 2024 and evaluates standard vs. titrated dosing approaches for patients age 65 and older with hr+/her2- metastatic breast cancer. centra also supports workshops, meetings, and research projects with other stakeholders in cancer research, including the nci, the fda's oncology center for excellence, and other non-profit groups, such as the friends of cancer research.

See schedule o:quality of care initiatives:quality oncology practice initiative (qopi) is a quality self-assessment and improvement program for outpatient medical oncology and hematology-oncology practices. qopi provides a web-based data collection tool that allows practices to 1) report on various cancer care quality measures, 2) receive analyzed data on practice performance, and 3) compare performance against their peers for data-driven improvement activities. practices participate annually and over 263 pratices particapted in 2024. quality training program. asco's quality training program is designed to educate and train hematolgy-onocology practice teams on the techniques of clinical care and operational performance quality improvement. 290 oncology professionals received training in 2024.guidelines. asco's guidelines program engages with more than 1,000 asco member volunteers, on a yearly basis, to develop expert recommendations and standards designed to promote consistent, safe delivery of high-quality cancer care worldwide. clinical content is disseminated using published articles, recommendation tables, algorithms, podcasts, visual abstracts, and other resources accessible through asco journals, the asco website, and the asco guidelines app. guidelines are among the most read articles in the journal of clinical oncology (jco), with over 1.1 million downloads and 503 citations in 2024. asco publishes between 25 and 30 new or updated guidelines each year, with a growing library of guideline summaries that have been translated into spanish. a total of 39 guideline products were published in the jco family of journals in 2024, including several rapid recommendations and multiple iterations of asco's comprehensive living guideline that addresses the care of patients with metastatic non-small cell lung cancer.

Policy:in collaboration with volunteer experts, asco works to address a wide range of policy issues that impact the cancer care delivery system and people with cancer. policy is conveyed in formal statements published in asco journals, and in public facing communications channels. areas of focus include quality and access to care, insurance issues, cost, prevention, survivorship, reimbursement, and support for clinical cancer research. in 2024, asco continued to draw public attention to the persistent crisis of drug shortages, the ongoing and worsening harms r